Ohio State researchers found in a preliminary study that spectroscopy detected fibromyalgia and differentiated the condition from similar ailments.
An assay based on a simple dye-protein interaction is now in clinical trials, with recent research suggesting it can accurately detect preeclampsia.
The firm recently announced a $3.15 million grant from the NIH, and it supported work that resulted in the first-ever digital primary diagnosis of a suspected cancer case.
The researchers plan to add the MSI detection capabilities to an NGS panel and will use the information to guide cancer patients to precision medicine trials.
The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis.